Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

Similar articles for PubMed (Select 23060565)

1.

Dermokine expression in intraductal papillary-mucinous neoplasm and invasive pancreatic carcinoma.

Watanabe K, Oochiai T, Kikuchi S, Kumano T, Matsui T, Morimoto K, Yasukawa S, Nakamori S, Sasako M, Yanagisawa A, Otsuji E.

Anticancer Res. 2012 Oct;32(10):4405-12. Erratum in: Anticancer Res. 2012 Nov;32(11):5137.

PMID:
23060565
2.

Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.

Oda Y, Aishima S, Morimatsu K, Hayashi A, Shindo K, Fujino M, Mizuuchi Y, Hattori M, Tanaka M, Oda Y.

Hum Pathol. 2013 Aug;44(8):1487-98. doi: 10.1016/j.humpath.2012.12.001. Epub 2013 Mar 1.

PMID:
23465281
3.
4.

Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.

Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T, Shimamoto F, Hiyama E.

J Surg Oncol. 2008 Apr 1;97(5):469-75.

PMID:
18161862
5.

Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.

Ikenaga N, Ohuchida K, Mizumoto K, Yu J, Kayashima T, Hayashi A, Nakata K, Tanaka M.

Hum Pathol. 2010 Oct;41(10):1466-74. doi: 10.1016/j.humpath.2010.04.004.

PMID:
20619441
6.

Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.

Takeshita A, Kimura W, Hirai I, Takasu N, Moriya T, Tezuka K, Watanabe T.

Pancreas. 2012 Jan;41(1):114-20. doi: 10.1097/MPA.0b013e318220c1fa.

PMID:
22143341
7.

Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.

Tanaka T, Kuroki T, Adachi T, Ono S, Hirabaru M, Soyama A, Kitasato A, Takatsuki M, Hayashi T, Eguchi S.

Pancreas. 2013 Apr;42(3):488-93. doi: 10.1097/MPA.0b013e318269d281.

PMID:
23146920
8.

S100P is a novel marker to identify intraductal papillary mucinous neoplasms.

Nakata K, Nagai E, Ohuchida K, Hayashi A, Miyasaka Y, Aishima S, Oda Y, Mizumoto K, Tanaka M, Tsuneyoshi M.

Hum Pathol. 2010 Jun;41(6):824-31. doi: 10.1016/j.humpath.2009.11.007. Epub 2010 Feb 12.

PMID:
20153506
10.

Multicentric invasive carcinomas derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas: report of a case.

Naitoh Y, Ban S, Tsuchiya C, Sugiura Y, Shimizu M.

Virchows Arch. 2007 Apr;450(4):487-90. Epub 2007 Feb 28. No abstract available.

PMID:
17333261
11.

MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).

Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.

Hepatogastroenterology. 2005 Mar-Apr;52(62):398-403.

PMID:
15816444
13.

Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas.

Fukushima N, Kikuchi Y, Nishiyama T, Kudo A, Fukayama M.

Mod Pathol. 2008 Aug;21(8):1044-53. doi: 10.1038/modpathol.2008.77. Epub 2008 May 16.

14.

Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.

Michaels PJ, Brachtel EF, Bounds BC, Brugge WR, Pitman MB.

Cancer. 2006 Jun 25;108(3):163-73.

15.

Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas.

Okada T, Masuda N, Fukai Y, Shimura T, Nishida Y, Hosouchi Y, Kashiwabara K, Nakajima T, Kuwano H.

Anticancer Res. 2006 Jul-Aug;26(4B):3105-10.

16.

Pdcd4 expression in intraductal papillary mucinous neoplasm of the pancreas: its association with tumor progression and proliferation.

Hayashi A, Aishima S, Miyasaka Y, Nakata K, Morimatsu K, Oda Y, Nagai E, Oda Y, Tanaka M, Tsuneyoshi M.

Hum Pathol. 2010 Nov;41(11):1507-15. doi: 10.1016/j.humpath.2010.02.019. Epub 2010 Jul 24.

PMID:
20656320
18.

Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine neoplasm.

Goh BK, Ooi LL, Kumarasinghe MP, Tan YM, Cheow PC, Chow PK, Chung YF, Wong WK.

Pancreatology. 2006;6(6):520-6. Epub 2006 Nov 23.

PMID:
17124434
19.

Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.

Fritz S, Hackert T, Hinz U, Hartwig W, Büchler MW, Werner J.

Br J Surg. 2011 Jan;98(1):104-10. doi: 10.1002/bjs.7280. Epub 2010 Oct 14.

PMID:
20949535
20.

Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.

Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C, Fléjou JF.

J Pathol. 2002 Aug;197(5):632-7.

PMID:
12210083
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk